Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the research poster entitled “Unipolar Intracardiac Signal Morphology as a Parameter for Catheter Contact Evaluation” […]